Nu Skin Enterprises, Inc. Expected to Post Q4 2022 Earnings of $0.50 Per Share (NYSE:NUS)

Nu Skin Enterprises, Inc. (NYSE:NUSGet Rating) – Research analysts at DA Davidson issued their Q4 2022 EPS estimates for Nu Skin Enterprises in a research report issued to clients and investors on Wednesday, November 23rd. DA Davidson analyst L. Weiser forecasts that the company will post earnings per share of $0.50 for the quarter. DA Davidson has a “Neutral” rating and a $34.00 price objective on the stock. The consensus estimate for Nu Skin Enterprises’ current full-year earnings is $2.57 per share.

Several other brokerages also recently issued reports on NUS. TheStreet downgraded shares of Nu Skin Enterprises from a “b” rating to a “c” rating in a research report on Thursday, August 4th. Citigroup decreased their target price on shares of Nu Skin Enterprises from $39.00 to $35.00 in a research report on Friday, November 4th. Finally, StockNews.com raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, November 4th.

Nu Skin Enterprises Trading Down 1.1 %

NUS opened at $38.54 on Thursday. The firm’s fifty day moving average is $36.65 and its two-hundred day moving average is $41.32. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.23 and a current ratio of 2.13. Nu Skin Enterprises has a twelve month low of $29.95 and a twelve month high of $56.76. The firm has a market cap of $1.90 billion, a PE ratio of 52.08 and a beta of 1.22.

Institutional Trading of Nu Skin Enterprises

A number of hedge funds have recently modified their holdings of the stock. Eagle Bay Advisors LLC lifted its stake in shares of Nu Skin Enterprises by 37.1% during the 2nd quarter. Eagle Bay Advisors LLC now owns 809 shares of the company’s stock worth $35,000 after buying an additional 219 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in Nu Skin Enterprises by 1.0% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 26,426 shares of the company’s stock worth $1,265,000 after purchasing an additional 272 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in Nu Skin Enterprises by 1.5% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 20,205 shares of the company’s stock worth $875,000 after purchasing an additional 292 shares in the last quarter. NorthCrest Asset Manangement LLC raised its stake in Nu Skin Enterprises by 3.5% in the 3rd quarter. NorthCrest Asset Manangement LLC now owns 8,900 shares of the company’s stock worth $297,000 after purchasing an additional 300 shares in the last quarter. Finally, Comerica Bank raised its stake in Nu Skin Enterprises by 1.3% in the 1st quarter. Comerica Bank now owns 23,484 shares of the company’s stock worth $1,150,000 after purchasing an additional 311 shares in the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.

Insider Buying and Selling at Nu Skin Enterprises

In other Nu Skin Enterprises news, Director Andrew D. Lipman sold 1,000 shares of the stock in a transaction on Thursday, September 22nd. The shares were sold at an average price of $36.67, for a total value of $36,670.00. Following the completion of the sale, the director now owns 69,393 shares in the company, valued at $2,544,641.31. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, CAO James D. Thomas sold 1,602 shares of the firm’s stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $39.19, for a total transaction of $62,782.38. Following the completion of the sale, the chief accounting officer now owns 12,722 shares in the company, valued at approximately $498,575.18. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Andrew D. Lipman sold 1,000 shares of the firm’s stock in a transaction dated Thursday, September 22nd. The stock was sold at an average price of $36.67, for a total transaction of $36,670.00. Following the sale, the director now owns 69,393 shares of the company’s stock, valued at approximately $2,544,641.31. The disclosure for this sale can be found here. Insiders sold a total of 4,602 shares of company stock worth $173,532 over the last quarter. 2.80% of the stock is currently owned by insiders.

Nu Skin Enterprises Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 7th. Investors of record on Friday, November 25th will be given a $0.385 dividend. This represents a $1.54 dividend on an annualized basis and a yield of 4.00%. The ex-dividend date of this dividend is Wednesday, November 23rd. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 208.11%.

Nu Skin Enterprises Company Profile

(Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Recommended Stories

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.